American Health and Drug Benefits

Scope & Guideline

Exploring the nexus of healthcare quality and pharmaceutical strategy.

Introduction

Delve into the academic richness of American Health and Drug Benefits with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1942-2962
PublisherENGAGE HEALTHCARE COMMUNICATIONS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2009 to 2023
AbbreviationAM HEALTH DRUG BENEF / Am. Health Drug Benefits
Frequency9 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address318 CLEVELAND AVE, HIGHLAND PARK, NJ 08904

Aims and Scopes

The journal 'American Health and Drug Benefits' focuses on the intersection of healthcare economics, policy, and pharmaceutical benefits, aiming to provide valuable insights into cost-effective treatment strategies and the management of healthcare resources.
  1. Healthcare Economics:
    The journal emphasizes research on the economic aspects of healthcare, including cost-effectiveness analyses and budget impact assessments for medications and treatments.
  2. Drug Utilization and Management:
    It covers studies related to the utilization patterns of drugs, including opioid management and medication therapy management, highlighting strategies to optimize drug use.
  3. Chronic Disease Management:
    The journal frequently publishes articles addressing the management of chronic diseases, including cancer and COPD, focusing on treatment patterns and healthcare costs.
  4. Health Disparities:
    Research on health disparities, particularly in medication adherence and access to care among different racial and ethnic groups, is a critical area of focus.
  5. Policy and Innovation in Healthcare:
    It explores policy implications and innovative approaches in healthcare delivery, particularly regarding the implementation of biosimilars and the impact of Medicare policies.
The journal has seen a shift towards addressing contemporary challenges in healthcare economics and drug management, reflecting emerging trends in the field.
  1. Real-World Evidence in Treatment Patterns:
    There is an increasing emphasis on real-world studies that analyze treatment patterns and healthcare costs, particularly in chronic conditions, which helps inform policy and practice.
  2. Cost-Effectiveness Analyses:
    Recent publications highlight a growing interest in cost-effectiveness studies for various treatments, signaling a trend towards evidence-based economic evaluations in healthcare.
  3. Integration of Biosimilars in Healthcare:
    The implementation strategies for biosimilars are gaining traction, reflecting a broader trend towards innovative treatment options and cost-containment strategies in the pharmaceutical sector.
  4. Addressing Racial and Ethnic Disparities:
    Research focusing on reducing health disparities, especially through Medicare Part D and medication management, is increasingly relevant, highlighting a commitment to equity in healthcare access.
  5. Impact of COVID-19 on Healthcare Practices:
    The effects of the COVID-19 pandemic on medication adherence and healthcare delivery models are emerging themes, indicating a response to the changing landscape of healthcare.

Declining or Waning

While the journal has a strong focus on various aspects of healthcare economics and drug benefits, some themes have shown a decline in prominence over recent years.
  1. Mental Health in Workplace Settings:
    Topics related to mental illness disclosure and workplace improvements have become less frequent, indicating a potential waning interest in this area within the journal's focus.
  2. Historical Perspectives on Healthcare:
    The exploration of historical narratives, such as the 'Government, Big Pharma, and the People' series, appears to be diminishing, suggesting a shift towards more contemporary issues.
  3. General Health Promotion Among College Students:
    Research specifically targeting health promotion and prescription drug misuse among college students seems to be less prevalent, indicating a decrease in focus on this demographic.

Similar Journals

Exploratory Research in Clinical and Social Pharmacy

Transforming challenges into solutions in pharmacy research.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.

Australian Health Review

Illuminating Paths to Improved Health Outcomes
Publisher: CSIRO PUBLISHINGISSN: 0156-5788Frequency: 5 issues/year

Australian Health Review is a prestigious peer-reviewed journal published by CSIRO PUBLISHING, focusing on the dynamic field of health policy. Established in 1980, this journal has continuously evolved to address contemporary health challenges in Australia and beyond, showcasing research that informs policy decisions and enhances health care delivery. With an impressive Q2 ranking in the sector of Health Policy and a Scopus rank of #162 out of 310, it holds a significant position in the academic community, offering vital insights to researchers, practitioners, and educators alike. Although not an open-access journal, it provides valuable research contributions that advance the discourse in health policy and practice. Located at UNIPARK, BUILDING 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA, the journal's comprehensive scope spans from 1980 to 2024, reflecting on the evolving landscape of health research. By disseminating high-quality studies, the Australian Health Review continues to play an essential role in shaping health policy and improving health outcomes.

International Journal of Clinical Pharmacy

Unlocking the Future of Pharmacy through Open Access Research
Publisher: SPRINGERISSN: 2210-7703Frequency: 6 issues/year

The International Journal of Clinical Pharmacy, published by Springer, serves as a pivotal platform for advancing research in the fields of Pharmaceutical Science and Pharmacology. This esteemed journal, recognized for its significant impact with an impressive Q1 ranking in Pharmacy and multiple Q2 designations, provides a dedicated space for scholars and practitioners to share innovative findings and methodologies that enhance clinical pharmacy practices. With an international reach and publication spanning from 2011 to 2024, the journal aims to facilitate knowledge exchange among researchers, professionals, and students, ultimately contributing to improved therapeutic outcomes. As an open-access journal, it promotes widespread dissemination of vital research, ensuring that cutting-edge clinical pharmacy knowledge is accessible to all stakeholders in the healthcare continuum.

JOURNAL OF AMBULATORY CARE MANAGEMENT

Driving excellence in ambulatory care through scholarly discourse.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0148-9917Frequency: 4 issues/year

JOURNAL OF AMBULATORY CARE MANAGEMENT, published by Lippincott Williams & Wilkins, is a leading peer-reviewed journal dedicated to advancing research and practice in the field of health policy, with a specific focus on ambulatory care management. Since its inception in 1978, this journal has served as a critical platform for disseminating innovative studies, insights, and methodologies that inform policy makers, healthcare professionals, and academic researchers alike. By maintaining an impressive ranking within the Q3 category in Health Policy and a Scopus rank of 148 out of 310, it underscores the journal's growing influence in shaping health policy discussions and decisions. The journal operates on a traditional subscription model, ensuring a high-quality review process while remaining accessible to those wishing to subscribe. With an ongoing commitment to excellence, the JOURNAL OF AMBULATORY CARE MANAGEMENT is essential for anyone involved in improving outcomes in ambulatory care settings and influencing health policy reforms, making it a must-read for researchers, practitioners, and students aiming to stay at the forefront of healthcare innovation.

Practical Diabetes

Advancing diabetes care through research and practice.
Publisher: JOHN WILEY & SONS LTDISSN: 2047-2897Frequency: 9 issues/year

Practical Diabetes is an esteemed journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Published by John Wiley & Sons Ltd, this journal serves as a vital resource for healthcare professionals, researchers, and students seeking to explore the latest findings and practical applications in the field of endocrinology. With an ISSN of 2047-2897, it has established itself as a respected outlet for impactful research since its inception in 2011, with a convergence period extending until 2024. Although currently listed in Q4 for Endocrinology, Diabetes, and Metabolism and Q3 for Internal Medicine, the journal is committed to improving its rank and increasing its relevance in a competitive academic landscape. While not an open-access publication, Practical Diabetes provides valuable insights and evidence-based practices that are crucial for improving patient outcomes. Researchers and practitioners alike will find a wealth of knowledge to inform their work and enhance their understanding of diabetes management, making this journal an essential addition to any academic library collection.

JAMA Health Forum

Advancing Health Policy for a Better Tomorrow
Publisher: AMER MEDICAL ASSOCISSN: 2689-0186Frequency:

Introducing the JAMA Health Forum, a premier journal published by the American Medical Association, dedicated to advancing knowledge in the critical fields of health policy and public health. Since its inception in 2020, this open-access journal has emerged as a leading platform for high-quality research, achieving a distinguished Q1 ranking in both Health Policy and Public Health, Environmental and Occupational Health for 2023. With an ISSN of 2689-0186, it provides a vital resource for researchers, policymakers, and students alike, facilitating widespread dissemination of impactful studies that aim to shape health strategies and improve community health outcomes. The JAMA Health Forum not only fosters collaboration among experts but also enhances global discussions on pressing health issues, making it an essential read for anyone involved in health-related research and practice.

Canadian Journal of Kidney Health and Disease

Empowering global insights into kidney disease.
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

Canadian Journal of Kidney Health and Disease, published by SAGE Publications Inc, is a leading open-access journal dedicated to advancing the field of nephrology. Established in 2014, the journal aims to bridge the gap between research and clinical practice by disseminating high-quality clinical and experimental research findings, reviews, and case studies that focus on kidney health and associated disorders. With an impressive impact factor and ranked in the Q2 category for nephrology, the journal fosters an environment for interdisciplinary collaboration and innovation, enhancing the visibility of crucial advancements in kidney disease research. As an open-access journal, it ensures that valuable knowledge is accessible to researchers, healthcare professionals, and students globally, facilitating a deeper understanding of kidney health issues and promoting improved patient care. Located in the United Kingdom, the journal continues to expand its reach and influence within the nephrology community, leveraging its open-access model to encourage a diverse audience in exploring cutting-edge findings and sharing insights pertinent to kidney health.

Journal of the American College of Clinical Pharmacy

Transforming pharmacy practice through scholarly excellence.
Publisher: WILEYISSN: Frequency: 6 issues/year

Welcome to the Journal of the American College of Clinical Pharmacy, a distinguished publication in the field of pharmacy and related health professions, published by WILEY since 2018. With a strong commitment to advancing clinical pharmacy practices, this journal serves as a vital resource for researchers, professionals, and students seeking to stay at the forefront of pharmaceutical science. Boasting impressive category quartiles, including Q2 in Pharmaceutical Science and Pharmacy, alongside a notable Scopus ranking in Health Professions and Pharmacology, it stands as a key platform for disseminating cutting-edge research and innovative approaches in clinical pharmacy. Although this journal maintains a subscription-based model, its rigorous peer review process and emphasis on high-quality research ensure that it continues to make significant contributions to the field. Join us in exploring the latest insights and developments from a community dedicated to improving patient care and health outcomes.

Journal of Pharmaceutical Policy and Practice

Exploring the intersection of healthcare and pharmaceutical sciences.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Journal of Pharmaceutical Policy and Practice, published by Taylor & Francis Ltd, is a premier open access journal dedicated to advancing the field of pharmaceutical policy and practice. Launched in 2013, this esteemed journal has rapidly become a vital resource for researchers, practitioners, and policymakers alike, offering a critical examination of health policies and their implementation in pharmaceutical contexts. With an impressive impact factor reflecting its significance, it ranks in the Q2 category for Health Policy and Q1 in both Pharmacology, Toxicology and Pharmaceutics and Pharmacy, showcasing its high-quality contributions to the field. Accessible to a global audience since 2014, the journal disseminates innovative research findings that inform best practices, foster policy development, and enhance patient outcomes in the pharmaceutical landscape. Positioned in the UK and with strong Scopus rankings, specifically ranked #3 in Health Professions (Pharmacy), the journal serves as an essential platform for those striving to navigate the ever-evolving intersection of healthcare and pharmaceutical sciences.

Health Care Management Science

Innovating strategies for optimal health care delivery.
Publisher: SPRINGERISSN: 1386-9620Frequency: 4 issues/year

Health Care Management Science, published by Springer, is a leading journal dedicated to advancing the fields of health care management and medical administration. With an impressive impact factor reflecting its strong academic influence and a Q1 quartile ranking in both Health Professions and Medicine categories, it stands out as a valuable resource for researchers, professionals, and students interested in optimizing health care systems. The journal, with its ISSN 1386-9620 and E-ISSN 1572-9389, features a variety of original research articles, case studies, and theoretical insights aimed at addressing contemporary challenges in health care. Spanning from 1998 to 2024, it continues to play a pivotal role in disseminating knowledge and best practices that enhance health care delivery and management strategies. Although it does not currently offer open access, its rigorous peer-review process ensures the publication of high-quality content that contributes significantly to the academic community and beyond.